共 2 条
[1]
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2006, 295 (19)
:2275-2285
[2]
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (01)
:26-37

